A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score.
Nutr Metab Cardiovasc Dis
; 26(5): 374-9, 2016 05.
Article
in En
| MEDLINE
| ID: mdl-27033025
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Glucose
/
Adamantane
/
Cardiovascular Diseases
/
Dipeptidyl Peptidase 4
/
Diabetes Mellitus, Type 2
/
Dipeptides
/
Dipeptidyl-Peptidase IV Inhibitors
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Nutr Metab Cardiovasc Dis
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
CIENCIAS DA NUTRICAO
/
METABOLISMO
Year:
2016
Document type:
Article
Country of publication: